Cargando…
Mechanistic Insights Into the Anticancer Properties of the Auranofin Analog Au(PEt(3))I: A Theoretical and Experimental Study
Au(PEt(3))I (AF-I hereafter), the iodide analog of the FDA-approved drug auranofin (AF hereafter), is a promising anticancer agent that produces its pharmacological effects through interaction with non-genomic targets such as the thioredoxin reductase system. AF-I is endowed with a very favorable bi...
Autores principales: | Tolbatov, Iogann, Cirri, Damiano, Marchetti, Lorella, Marrone, Alessandro, Coletti, Cecilia, Re, Nazzareno, La Mendola, Diego, Messori, Luigi, Marzo, Tiziano, Gabbiani, Chiara, Pratesi, Alessandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7531625/ https://www.ncbi.nlm.nih.gov/pubmed/33195032 http://dx.doi.org/10.3389/fchem.2020.00812 |
Ejemplares similares
-
Mechanistic
Evaluations of the Effects of Auranofin
Triethylphosphine Replacement with a Trimethylphosphite Moiety
por: Ronga, Luisa, et al.
Publicado: (2023) -
Anti-Staphylococcal Activity of the Auranofin Analogue Bearing Acetylcysteine in Place of the Thiosugar: An Experimental and Theoretical Investigation
por: Chiaverini, Lorenzo, et al.
Publicado: (2022) -
Reactions of Arsenoplatin-1 with Protein Targets:
A Combined Experimental and Theoretical Study
por: Tolbatov, Iogann, et al.
Publicado: (2022) -
Computational Studies of Au(I) and Au(III) Anticancer MetalLodrugs: A Survey
por: Tolbatov, Iogann, et al.
Publicado: (2021) -
Medicinal Hypervalent Tellurium Prodrugs Bearing Different Ligands: A Comparative Study of the Chemical Profiles of AS101 and Its Halido Replaced Analogues
por: Chiaverini, Lorenzo, et al.
Publicado: (2022)